⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Trispecific Antibodies Market Landscape Report 2026: Opportunity and Proprietary Insights - 90 Trispecific Antibodies by Company, Country, Indication & Phase
globenewswire.com
MRK
JNJ
ABBV
OPK
Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge
globenewswire.com
AZN
MRK
BMY
PFE
AMGN
Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR
globenewswire.com
TMO
MRK
GEHC
AZN
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL USA - English USA - English
prnewswire.com
MRK
GSK
GILD
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL USA - English USA - English
prnewswire.com
MRK
GSK
GILD
Foundation Fighting Blindness to Host United in Vision 2026 Conference in Partnership with Retina International World Congress
prnewswire.com
AMGN
ALKS
BLCO
AMR
MRK
REGN
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
businesswire.com
MRK
Healthcare Filtration Markets 2025-2035 with Focus on Biologics Manufacturing Featuring Alfa Laval, Asahi Kasei, Cobetter, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher Scientific
globenewswire.com
AMAT
COR
MRK
PH
TMO
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
globenewswire.com
EVAX
MRK
U.S. Chamber Discusses How Medical Breakthroughs Are Extending Lives and Strengthening the Economy with YourUpdateTV
globenewswire.com
MRK
PFE
JNJ
BMY
GILD
LLY
AMGN
REGN
ABBV
BIIB